Royal Canin Executive and Leadership Team

August, 2026

Leadership Overview

Royal Canin has 5 executives leading key functions including financial strategy, regional market operations, information systems, and global veterinary medicine.

Driven by a commitment to precise animal nutrition, Royal Canin advances the health of cats and dogs through scientific research and targeted dietary formulations for global markets.

Leadership Roles at Royal Canin

  • Chief Financial Officer - Agatha Doerffer
  • Chief Financial Officer, LATAM Seeds (Colombia, Chile, Puerto Rico Y Peru) - Isabel Orozco
  • Regional President (North America) - Daryn Brown
  • Global Chief Medical Officer - Brent Mayabb
  • Information - Phimwanala Danladi
  • Agatha Doerffer - Chief Financial Officer

    Agatha Doerffer, the Chief Financial Officer at Royal Canin, directs all fiscal planning and capital allocation strategies. Overseeing the financial health of the organization, the Chief Financial Officer ensures that investments in nutritional research and development align with long-term profitability goals. This leadership role involves managing complex budgetary frameworks across international manufacturing facilities to support the production of specialized pet nutrition. By optimizing cost structures and monitoring global market performance, Agatha Doerffer directly impacts the ability of the company to scale operations effectively. The Chief Financial Officer maintains rigorous oversight of financial reporting, providing the necessary data for strategic decision-making at the executive level. Through disciplined fiscal management, Doerffer secures the resources required for continuous innovation in feline and canine dietary solutions, ultimately strengthening the market position of the organization within the competitive pet products industry.

    Isabel Orozco - Chief Financial Officer, LATAM Seeds (Colombia, Chile, Puerto Rico Y Peru)

    Isabel Orozco, the Chief Financial Officer, LATAM Seeds (Colombia, Chile, Puerto Rico Y Peru) at Royal Canin, manages financial operations across diverse Latin American markets. Overseeing regional fiscal performance, the Chief Financial Officer, LATAM Seeds (Colombia, Chile, Puerto Rico Y Peru) ensures that local distribution networks maintain profitability while adhering to corporate standards. This leadership role involves navigating complex regulatory environments and currency fluctuations to sustain growth in the regional pet nutrition sector. By implementing robust financial controls, Isabel Orozco supports the expansion of specialized product availability for veterinary professionals and retailers throughout the territory. The Chief Financial Officer, LATAM Seeds (Colombia, Chile, Puerto Rico Y Peru) collaborates with global leadership to integrate regional insights into the broader corporate strategy. Through strategic resource allocation, Orozco drives operational efficiency, ensuring that the unique nutritional requirements of animals in these specific regions receive consistent support through optimized supply chain investments.
    Isabel Orozco

    Daryn Brown - Regional President (North America)

    Daryn Brown, the Regional President (North America) at Royal Canin, directs all commercial activities and market expansion initiatives across the North American continent. Overseeing the distribution of specialized nutritional products, the Regional President (North America) ensures that veterinary clinics and retail partners receive high-quality solutions tailored to specific animal health needs. This leadership role involves managing large-scale operations and fostering relationships with key industry stakeholders to increase brand penetration. By analyzing regional consumer trends and pet health data, Daryn Brown shapes the strategic direction for product availability and marketing efforts. The Regional President (North America) coordinates with global teams to align local execution with the overarching mission of scientific nutritional excellence. Through effective management of regional teams, Brown drives revenue growth and operational success, ensuring that the company remains the preferred choice for pet owners seeking breed-specific and health-focused dietary formulations throughout the North American market.

    Brent Mayabb - Global Chief Medical Officer

    Brent Mayabb, the Global Chief Medical Officer at Royal Canin, directs the scientific validation and medical integrity of all nutritional product formulations. Overseeing the research and development protocols, the Global Chief Medical Officer ensures that every product addresses the specific physiological requirements of cats and dogs based on breed, size, and health status. This leadership role involves leading teams of veterinary experts to conduct rigorous testing that informs the company's specialized dietary solutions. By bridging the gap between clinical veterinary science and product manufacturing, Brent Mayabb maintains the high standards of nutritional excellence expected by veterinary professionals globally. The Global Chief Medical Officer collaborates with the board to define the long-term scientific roadmap for the organization. Through continuous investigation into animal health, Mayabb drives innovation, ensuring that the company remains at the forefront of evidence-based pet nutrition and provides effective solutions for diverse health conditions.

    Phimwanala Danladi - Information

    Phimwanala Danladi, the Information at Royal Canin, architects the digital infrastructure and data management systems that support global nutritional research. Overseeing the integration of advanced technology, the Information ensures that scientific data regarding feline and canine dietary needs remains accessible and secure across all manufacturing facilities. This leadership role involves implementing sophisticated analytics platforms to track product formulation efficacy and supply chain performance. By modernizing digital workflows, Phimwanala Danladi enhances the ability of the organization to respond to emerging health trends in companion animals. The Information collaborates with research teams to translate complex biological data into actionable insights for product development. Through the deployment of scalable information systems, Danladi supports the company's commitment to precision nutrition, ensuring that every nutritional solution reflects the latest scientific findings while maintaining operational excellence across the international distribution network of the organization.

    Explore Leadership Teams in Manufacturing

    Frequently Asked Questions Regarding Royal Canin Top Executives and Leadership Team

    Who leads Royal Canin?
    Royal Canin is led by Agatha Doerffer (Chief Financial Officer), along with executives such as Isabel Orozco (Chief Financial Officer, LATAM Seeds (Colombia, Chile, Puerto Rico Y Peru)) and Daryn Brown (Regional President (North America)).
    Who is part of Royal Canin’s executive team?
    The executive team of Royal Canin includes leaders such as Agatha Doerffer (Chief Financial Officer), Isabel Orozco (Chief Financial Officer, LATAM Seeds (Colombia, Chile, Puerto Rico Y Peru)), Daryn Brown (Regional President (North America)) and other senior executives.
    How many executives does Royal Canin have?
    Royal Canin has 5 executives leading key business areas.
    What roles are included in Royal Canin’s leadership team?
    The leadership team of Royal Canin includes roles such as Chief Financial Officer, Chief Financial Officer, LATAM Seeds (Colombia, Chile, Puerto Rico Y Peru), Regional President (North America), Global Chief Medical Officer, Information.